section name header

Basics

[Section Outline]

Author:

Roger M.Barkin

Suzanne Z.Barkin


Description!!navigator!!

Etiology!!navigator!!

Diagnosis

[Section Outline]

ALERT
UTIs in children may be difficult to diagnose without lab confirmation

Signs and Symptoms!!navigator!!

History

  • Often nonspecific
  • Neonates:
    • Manifestations of sepsis
    • Feeding difficulties
    • Irritability, listlessness
    • Fever, hypothermia
  • 1 mo-3 yr of age:
    • Fever
    • Irritability
    • Vomiting, diarrhea
    • Abdominal pain
    • Poor feeding, failure to thrive (slowing growth pattern)
  • Hematuria
  • In girls <2 yr, an increased risk is associated with those having 3 factors (<12 mo old, white, temperature 39°C, absence of other source of fever, fever 2 d)
  • Children >3 yr of age:
    • Dysuria
    • Frequency
    • Enuresis
    • New onset of urinary incontinence
    • Pain: Abdominal, suprapubic, back, costovertebral angle (CVA)
    • Fever
    • Hematuria
    • Malodorous cloudy urine
    • Systemic toxicity: High fever and chills with CVA tenderness
  • Complications:
    • Recurrent UTI
    • Pyelonephritis
    • Chronic renal failure:
      • Scarring probably may be reduced by early detection and intervention although some evidence supports that the scarring represents a congenital finding
    • Perinephric abscess
    • Bacteremia/sepsis
    • Urolithiasis

Physical Exam

  • Vital signs, esp. temperature and blood pressure
  • Toxicity
  • Growth parameters
  • Abdomen: Tenderness, esp CVA pain
  • GU: Genitalia

Essential Workup!!navigator!!

Diagnostic Tests & Interpretation!!navigator!!

Lab

  • CBC and blood culture for young children with fever or nonspecific symptoms and no source on exam. Consider additional evaluation as appropriate
  • Electrolytes, BUN, creatinine:

Imaging

  • Children requiring radiologic evaluation:
    • Infants <3 mo of age
    • Males (increased association with anomaly) with first UTI
    • Clinical signs and symptoms consistent with pyelonephritis
    • Clinical evidence of renal disease
    • Some suggest that girls <3 yr of age with a first UTI should be studied
    • Females >3 yr of age
    • First UTI in patients who have a family history of UTIs, abnormal voiding pattern, poor growth, HTN, urinary tract anomalies, or failure to respond promptly to therapy
    • Second UTI
  • Voiding cystourethrogram (VCUG):
    • UTI is often associated with VUR and other genitourinary abnormalities and identified by VCUG. The importance of identifying VUR has been questioned
    • Indicated if there is hydronephrosis or significant scarring
  • Renal/bladder US:
    • Ultrasonography is useful in excluding obstructive lesion and identifying children with solitary/ectopic kidney and some patients with moderate renal damage/scarring:
      • Renal/bladder US is indicated to identify anatomic abnormalities. Should be done in children <2 yr with first febrile UTI, children with recurrent febrile UTIs, children with a UTI and family history of GU disease, poor growth, or hypertension as well as those children who do not respond as anticipated to antibiotics
      • Nuclear cystogram (99Tc DMSA scan). Useful in documenting scarring and reflux nephropathy
    • Further evaluation with nuclear medicine studies depends upon the grade of VUR and response to treatment

Differential Diagnosis!!navigator!!

Treatment

[Section Outline]

Initial Stabilization/Therapy!!navigator!!

ED Treatment/Procedures!!navigator!!

Medication!!navigator!!

First Line

  • Amoxicillin: 40 mg/kg/24 hr PO q8h
  • Amoxicillin/clavulanate: 40 mg/kg/24 hr PO q8h
  • Ampicillin: 100 mg/kg/24 hr IV q6h
  • Cefdinir 14 mg/kg/24 hr PO per day
  • Cefixime 16 mg/kg/24 hr PO on first day followed by 8 mg/kg/24 hr PO per day
  • Ceftriaxone: 50-75 mg/kg/24 hr q12-24h IV/IM
  • Cephalexin: 50 mg/kg/24 hr PO q6-12h
  • Gentamicin: 2.5 mg/kg/dose IV q8h if full-term and age >7 d; 2.5 mg/kg/dose IV q12h if full term and age 0-7 d (special dosing regimens in infants <36 wk postconceptual age)
  • TMP-SMX (Bactrim or Septra suspension): 5 mL liquid (of 40/200 per 5 mL) per 10 kg per dose PO b.i.d

Follow-Up

[Section Outline]

Disposition!!navigator!!

Admission Criteria

  • Infants <3 mo
  • Dehydration
  • Ill appearance/toxicity/sepsis
  • Suspected pyelonephritis
  • Urinary obstruction
  • Vomiting, unable to retain medications
  • Failure to respond to outpatient therapy
  • Immunocompromised patient
  • Renal insufficiency
  • Foreign body (indwelling catheter)
  • Pregnant patient

Discharge Criteria

  • Sufficiently hydrated
  • Low risk for sepsis or meningitis
  • Nontoxic
  • Able to take oral antibiotics; compliant

Issues for Referral

  • Patients needing admission often require a pediatrician, urologist, or infectious disease consultant, esp if there is VUR, renal anomaly, impaired renal function, recurrent infection, or hypertension
  • Good follow-up is mand atory

Follow-up Recommendations!!navigator!!

Monitoring of urine for sterility, monitoring for fever, further evaluation for underlying pathology, and following growth pattern

Pearls and Pitfalls

  • UTI may require lab confirmation of clinical suspicion. Signs and symptoms are often nonspecific
  • Febrile infants with UTI may be bacteremic
  • Neonates with UTI may have normal urinalysis

Additional Reading

See Also (Topic, Algorithm, Electronic Media Element)

Codes

ICD9

ICD10

SNOMED